Patents Assigned to TranXenoGen, Inc.
  • Anticancer peptide compositions
    Patent number: 7326679
    Abstract: The invention provides compositions and methods for inhibiting angiogenesis associated with tumors and reducing tumor growth.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: February 5, 2008
    Assignee: TranXenoGen, Inc.
    Inventors: Nathan H. Sloane, Kathleen M. Hehir, Alexander Baguisi, Paul DiTullio